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Hybrid muscular ventricular septal defect closure:
Surgeon or physician!!Nageswara Rao Koneti*
Consultant Paediatric Cardiologist, Care Hospital, Hyderabad 500034, Andhra Pradesh, IndiaWebster dictionary defines, “hybrid is a union or offspring of
two distinct species either animal or plant”. Some may argue
that surgeons and interventional cardiologists are definitely
two different species (John P. Cheatham).
Perventricular device closure is performed by both surgeon
and cardiologist in hybrid suit or operating room combining
catheterization and surgical techniques have been described
elsewhere.1 This hybrid procedure is useful in a subset of
infants, who are otherwise at high risk for surgery or inter-
ventional closure. Amin et al first reported successful per-
ventricular device closure in an infant with post operative
residual mVSD.2 The indications and guidelines for hybrid
perventricular device closure have not been clearly described
in literature. However, most of the published data suggests
that small babies lesser than 5 kg, children with muscular
ventricular septal defects (mVSDs) and other associated
cardiac defects requiring simultaneous repair, who are
otherwise at high risk for surgical closure are probably ideal
for perventricular device. There is no absolute contraindica-
tion to this technique. The present series in this issue by
Thakkar et al is probably one of the largest single centre series
of perventricular device closure in young children. The
authors are congratulated for the nice piece of work in this
difficult subset of population. Their study elaborates the
technique, complications and outcome of the procedure.3
The basic question is ‘why a perventricular device closure
should be performed’?When surgery or intervention alone are
not giving any satisfactory result for a given problem or when
the combination of two fields become less traumatic to the
patientwith a better final outcome. Themajor advantages are:
from surgeon’s view; i) easy accessibility of mVSD even in
difficult locations ii) no palliative pulmonary artery banding or
ventriculotomy required to close the apical mVSD iii) no ill* Tel.: þ91 (0) 9701300455.
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http://dx.doi.org/10.1016/j.ihj.2012.10.003effects of CPB; from cardiologist’s view; i) no limitation for
vascular access and sheath size ii) no hemodynamic insta-
bility due to arterio-venous looping iii) septum can be
approached from anterior (perpendicular angle) but, not from
a lateral (tricuspid valve) plane.
The patient population of present study in this issue
by Thakkar et al is much younger with a mean weight of
<5 kg in less than 6 months of age. The surgical closure of
mVSD in younger infants carries higher risk for residual VSD
and ventricular dysfunction due to ventriculotomy. Yeager et
at reported as high as 7.8% mortality in their series.4 The
subset of population in the current series seems to be ideal
for perventricular device closure. They have successfully
closed the defect in 21 of 24 patients. However, the compli-
cations include e two procedure related deaths, esophageal
tear and development of complete heart block. The authors
of this study included only isolated muscular VSD however;
this hybrid method is useful especially in closing difficult
VSDs associated with complex congenital heart defects like
double outlet right ventricle, D-Transposition of great vessels.
Technical issues of the perventricular device closure
include; first the optimal puncture site on the right ventricle to
have a favorable perpendicular angle to cross the defect with
a guide wire, second the placement of introducer sheaths.
Identification of puncture site on free wall of right ventricle is
an important step for the success of perventricular closure.
Crossland et al, described indentation of the right ventricle by
the surgeon’s finger until echo demonstrates a bulge perpen-
dicular to the VSD.5 The puncture area should be free fromany
coronary artery and second the indentation by the index
finger should correspond to the mVSD. This will give
perpendicular angle and paves easy route for insertion of
sheath and deployment of the LV disc. A close collaborationty of India. All rights reserved.
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necessary to achieve superior results at this point. Bacha et al,
described transcatheter crossing of VSD and snaring by per-
ventricular approach in difficultmVSD.6 One of the drawbacks
of transcatheter closure is malalignment of the device during
deployment due to lack of control on the delivery sheath and it
can be overcome by this method. The authors of the present
study followed the traditional method of pre-soaking the
device in the patient’s own blood to prevent immediate intra-
device shunt. This practice is no longer followed due to the
quantum of transient shunt is insignificant.
The authors of this study took all steps to reduce the cost
significantly by doing first 18 cases in operating room and
subsequently in cardiac catheterization laboratory after gain-
ing experience. At present, there are hardly any hybrid suits in
the country performing procedures essentially, because of the
cost and lack of infrastructure. Development of indigenous
hybrid suits and accurate planning of the space will probably
solve some of these problems.7 Themuscular occluder used in
the present study was Cardi-O-Fix (Starway Medi Tech, Inc.
Beijing, China) has similarities with Amplatzer mVSD
occluder. Thiswas preferred again, probably because of its low
cost. Moreover, less ventilator time and hospital stay reduces
the expenditure. This procedure is devoid of ill effects of CPB.
The complication rate appears to be minimally higher
however; the subset of patient population is much younger
and all presented either with heart failure, respiratory infec-
tion or malnutrition. Twenty-one of 24 were successfully
treated with this hybrid procedure and only three patients
were converted surgically after an initial attempt of perven-
tricular closure. Important steps to be taken to prevent injury
to the cardiac structures are viz., the dilator tip should not be
inserted too deep to injure the left ventricular (LV) posterior
wall. The sheath-dilator length within the heart should never
be more than the measurement of distance from the right
ventricular (RV) free wall to LV internal dimension by echo-
cardiogram. The introducer and dilator are stiff instruments
designed for percutaneous puncture. The dilator can easily
straighten the glide wire and cause perforation of the LV
posterior wall. Marking on the sheath which corresponds to
distance from external surface of RV free wall to internal
dimension of LV will help to prevent excess insertion of the
sheath-dilator assembly. The other usefulmarkings on sheath
and cable are distance from the free wall to mVSD, so that the
device can be released approximately at the LV side of the
septum. With utmost precautions, the authors could manage
to position the sheath anddevice accurately inmost cases. The
LV disc should be released away from the mitral apparatus
underTEEmonitoring. Rarely, bulkydevice ina small babymay
produce LV outflow tract obstruction. Careful selection of the
cases will prevent these rare but significant complications.
The mechanisms of CHB in the present series are
unknown hence; close follow up is needed even in mVSD.
Two patients developed CHB needing permanent pacemaker
in one. The stress by the device beyond the perimembranous
septum probably produced conduction disturbance.
Ventricular arrhythmia is an interesting complication of the
study and the authors have documented electrolyte distur
bance as a provocative factor; the irritation by the devicecould have triggered the arrhythmia in this child in the
presence of hypokalemia. The electro thermal energy
released during the trans-esophageal echocardiogram (TEE)
always should be taken into consideration especially in
younger children. The duration of TEE is important apart
from the size of the TEE probe to produce esophageal tears.
Hemodynamic instability and blood loss during the proce-
dure are other complications of perventricular device. On
contrary, transcatheter closure of mVSD is not totally devoid
of complications, Holzer et al, in their multicenter study
showed major complications in 10.7% of population such as
device migration, wire perforation and hemodynamic
compromise due to arrhythmia, and the overall incidence
rate was as high as 45%.8 Most of the patients in the present
series were benefitted and showed improvement in heart
failure and malnutrition on follow up.
The fundamental question to be asked while balancing the
judgment before doing perventricular device is what is the risk
benefit ratio to the patient? Bach et al, in their multicenter study
showed good results in three groups of patients. They did not
encounter any complications and all 12 patients were
asymptomatic at median follow up of 12 months.9 Neverthe-
less, the risk of surgery or interventional closure should be
weighed against the minimally invasive perventricular
closure in this subset of patients.r e f e r e n c e s
1. Bacha EA, Cao QL, Starr JP, Waight D, Ebeid MR, Hijazi ZM.
Perventricular device closure of muscular ventricular septal
defects on the beating heart: technique and results. J Thorac
Cardiovasc Surg. 2003;126:1718e1723.
2. Amin Zahid, Berry James M, Foker John E, Rocchini Albert P,
Bass John L. Intraoperative closure of muscular ventricular
septal defect in a caninemodel and application of the technique
in a baby. J Thorac Cardiovasc Surg. 1998;115:1374e1376.
3. Thakkar B, Patel N, Shah S, et al. Perventricular device closure
of isolated muscular ventricular septal defect in infants: A
single center experience. Indian Heart J. 2012;64:559e567.
4. Yeager SB, Freed MD, Keane JF, Norwood WI, Castaneda AR.
Primary surgical closure of ventricular septal defect in the first
year of life: results in 128 infants. J Am Coll Cardiol.
1984;3(5):1269e1276.
5. Crossland DS,Wilkinson JL, Cochrane AD, d’Udekem Y,
Brizard CP, Lane GK. Initial results of primary device closure of
large muscular ventricular septal defects in early infancy using
perventricularaccess.CatheterCardiovasc Interv. 2008;72:386e391.
6. Bacha Emile AM, Hijazi Ziyad M. Hybrid procedures in
pediatric cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr
Card Surg Annu. 2005;8:78e85.
7. Anuradha S, Subramanyan Raghavan, Agarwal Ravi, Pezzella A
Thomas, Cherian KM. Hybrid stage I palliation for hypo-plastic
left heart condition without a hybrid suite: suggestions for
developing nations. Indian Heart J. 2012;64(4):333e337.
8. HolderR, BalzerD, CaoQL, LockK,Hijazi ZMAmplatzerMuscular
Ventricular Septal Defect Investigators. Device closure of
ventricular septal defects using the Amplatzer muscular
ventricular septal defect occluder: immediate andmid-term
results of a U.S. registry. J Am Coll Cardiol. 2004;43:1257e1263.
9. Bacha EA, Cao QL, Galantowicz ME, et al. Multi center
experience with perventricular device closure of muscular
ventricular septal defects. Pediatr Cardiol. 2005;26:169e175.
